Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: RANDOMISED CONTROLLED TRIAL: Patients are allocated into two groups either group A( homoeopathic medicine+ modern medicine) or Group B(placebo+ modern medicine) through random numbers o
Sponsors
Dr ARCHANA CHANDRAN
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who are previously diagnosed with Type 2 Diabetes mellitus and are taking oral antidiabetic drugs 2) HbA1c levels >6.5%
Exclusion criteria
Exclusion criteria: 1) Patients with type 1 diabetes 2) Case of uncontrolled Diabetes mellitus and its complications 3) Cases with malignant hypertension 4) Patients who are taking insulin therapy 5) Pregnant women and lactating mothers 6) Known underlying immune deficiencies/serious illness (TB, cancer, AIDS)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The outcome measurement will be done by assessing the changes in HbA1c values at an interval of 3 months and FPG&PPBS once in a month from baseline to 12 months for both groupsTimepoint: 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| A reduction in the number and dose of modern medicine after the integration of homoeopathic medicine will be considered as significant to the study after the statistical analysisTimepoint: 12 months | — |
Countries
India
Contacts
Public ContactDr R S KRISHNESWARI
NATIONAL HOMOEOPATHY RESEARCH INSTITUTE IN MENTAL HEALTH
Outcome results
None listed